Clinical Trial Update: EASE (Efficacy of ATX01 Study in Erythromelalgia) [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for ATX01 in erythromelalgia has completed enrollment and status is reported as completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Erythromelalgia

Drugs mentioned

• ATX01

Snippet

Sponsor: AlgoTherapeutix | Conditions: Erythromelalgia | Phase 2 | Status: COMPLETED